Previous 10 | Next 10 |
SEATTLE and VANCOUVER, British Columbia , July 31, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the Uni...
4 Penny Stocks To Watch This Month One of the best parts about penny stocks is that there are thousands of them. Seriously, think about it. If you miss a breakout on one penny stock, there are plenty more to watch that have a real chance of big moves, regardless. It’s one of the reaso...
Achieve Life Sciences to Announce Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 6, 2020 Canada NewsWire SEATTLE and VANCOUVER, British Columbia, July 28, 2020 SEATTLE and VANCOUVER, British Columbia , July 28, 2020 /CNW/ -- ...
4 Penny Stocks To Watch Before The 4th Of July Holiday Weekend We’re heading into a unique week for all penny stocks , blue-chips , etc. Not only is it going to be the end of the month and second quarter, it’s also a short week that kicks off July and Q3. Given this as the case...
Achieve Life Sciences (NASDAQ: ACHV ) +6.10% PM, entered into a securities purchase agreement for purchase and sale of 14.63M shares at a price of $0.41 per share in a registered direct offering, resulting in total gross proceeds of ~$6M. More news on: Achieve Life Sciences, ...
SEATTLE and VANCOUVER, BC , June 29, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announce...
Achieve Announces Successful Results from the Investigator-Initiated RAUORA Head-to-Head Non-Inferiority Clinical Trial Comparing Cytisinicline and Chantix® (varenicline) as a Treatment to Quit Smoking Canada NewsWire SEATTLE and VANCOUVER, BC, June 29, 2020 Cytisinic...
Achieve Life Sciences, Inc. (ACHV) Q1 2020 Results Earnings Conference Call May 14, 2020, 08:00 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer John Bencich - Chief Financial Officer and Operating Officer ...
Achieve Life Sciences (NASDAQ: ACHV ) provides an update on the cytisinicline clinical development program. More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Read more ...
Achieve Life Sciences (NASDAQ: ACHV ): Q1 GAAP EPS of -$0.11 beats by $0.01 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutic...
SEATTLE and VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced it ...
SEATTLE and VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ:ACHV), a late-stage pharmaceutic...